PL331523A1 - Azolotrizines and azolopyrimidines - Google Patents

Azolotrizines and azolopyrimidines

Info

Publication number
PL331523A1
PL331523A1 PL97331523A PL33152397A PL331523A1 PL 331523 A1 PL331523 A1 PL 331523A1 PL 97331523 A PL97331523 A PL 97331523A PL 33152397 A PL33152397 A PL 33152397A PL 331523 A1 PL331523 A1 PL 331523A1
Authority
PL
Poland
Prior art keywords
azolotrizines
azolopyrimidines
Prior art date
Application number
PL97331523A
Other versions
PL195762B1 (en
Inventor
Argyrios Georgious Arvanitis
Robert John Chorvat
Liqi He
Paul Joseph Gilligan
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Priority claimed from PCT/US1997/013072 external-priority patent/WO1998003510A1/en
Priority claimed from US08/899,242 external-priority patent/US6124289A/en
Publication of PL331523A1 publication Critical patent/PL331523A1/en
Publication of PL195762B1 publication Critical patent/PL195762B1/en

Links

PL97331523A 1996-07-24 1997-07-23 Azolotrizines and azolopyrimidines PL195762B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2329096P 1996-07-24 1996-07-24
US68604796A 1996-07-24 1996-07-24
PCT/US1997/013072 WO1998003510A1 (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines
US08/899,242 US6124289A (en) 1996-07-24 1997-07-23 Azolo triazines and pyrimidines

Publications (2)

Publication Number Publication Date
PL331523A1 true PL331523A1 (en) 1999-07-19
PL195762B1 PL195762B1 (en) 2007-10-31

Family

ID=27362048

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97331523A PL195762B1 (en) 1996-07-24 1997-07-23 Azolotrizines and azolopyrimidines

Country Status (15)

Country Link
JP (2) JP4704521B2 (en)
CN (3) CN1104432C (en)
AR (1) AR049583A2 (en)
BR (1) BR9710544A (en)
CA (1) CA2259583C (en)
CZ (1) CZ299451B6 (en)
EA (1) EA004403B1 (en)
EE (1) EE04316B1 (en)
HR (1) HRP970413A2 (en)
IL (4) IL127871A0 (en)
NO (1) NO315610B3 (en)
NZ (1) NZ333777A (en)
PL (1) PL195762B1 (en)
SI (1) SI9720045B (en)
SK (1) SK286461B6 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05433B1 (en) * 2001-03-13 2011-06-15 Bristol-Myers Squibb Pharma Company 4- (2-Butylamino) -2,7-dimethyl-8- (2-methyl-6-methoxypyrid-3-yl) [1,5-a ] p rasolo-1,3,5-triazine, its pharmaceutically acceptable prodrugs or pharmaceutically acceptable salts, and their use
WO2004110454A1 (en) * 2003-06-13 2004-12-23 Ishihara Sangyo Kaisha, Ltd. COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
GB0519957D0 (en) * 2005-09-30 2005-11-09 Sb Pharmco Inc Chemical compound
CN101516887B (en) * 2006-09-20 2011-11-02 伊莱利利公司 Thiazole pyrazolopyrimidines as crf1 receptor antagonists
CN103694242B (en) * 2013-12-10 2016-01-06 昆明翔昊科技有限公司 Pyrazolopyrimidines and pharmaceutical composition thereof and its application in pharmacy
CN112608316B (en) * 2019-07-30 2022-10-21 厦门宝太生物科技股份有限公司 Pyrazolotriazine adenosine receptor antagonist
BR112023002497A2 (en) 2020-08-12 2023-05-02 Spruce Biosciences Inc METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC OVARIAN SYNDROME
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995039A (en) * 1975-05-27 1976-11-30 Merck & Co., Inc. Pyrazolo [1,5-a] [1,3,5] triazines
JPS6157587A (en) * 1984-08-29 1986-03-24 Shionogi & Co Ltd Condensed heterocyclic derivative and antiulcerative
US4824834A (en) * 1986-10-31 1989-04-25 Otsuka Pharmaceutical Company, Limited Pyrazolotriazine compounds
JP2691317B2 (en) * 1989-08-25 1997-12-17 株式会社大塚製薬工場 4-Hydroxy-8- (3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo [1,5-a] -1,3,5-triazine optically active salts and process for producing the same
US5420128A (en) * 1990-10-09 1995-05-30 Otsuka Pharmaceutical Co., Ltd. Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor
EP0591528B1 (en) * 1991-04-22 1998-12-23 Otsuka Pharmaceutical Factory, Inc. PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND ANTI-INFLAMMATORY CONTAINING THE SAME
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
IL164513A (en) 2010-04-29
BR9710544A (en) 1999-08-17
CA2259583A1 (en) 1998-01-29
JP2005097257A (en) 2005-04-14
JP4194539B2 (en) 2008-12-10
EA004403B1 (en) 2004-04-29
CZ18499A3 (en) 1999-11-17
JP2002513382A (en) 2002-05-08
IL127871A0 (en) 1999-10-28
CN1225637A (en) 1999-08-11
AR049583A2 (en) 2006-08-16
IL127871A (en) 2010-04-29
CN1250223C (en) 2006-04-12
NO990264L (en) 1999-03-10
EE9900019A (en) 1999-08-16
HRP970413A2 (en) 1998-10-31
NO315610B1 (en) 2003-09-29
EA199900158A1 (en) 1999-10-28
NO990264D0 (en) 1999-01-21
SK286461B6 (en) 2008-10-07
CA2259583C (en) 2009-11-17
CN1104432C (en) 2003-04-02
SI9720045B (en) 2008-02-29
CZ299451B6 (en) 2008-07-30
EE04316B1 (en) 2004-06-15
SK9799A3 (en) 2005-04-01
IL150163A (en) 2010-12-30
JP4704521B2 (en) 2011-06-15
IL164513A0 (en) 2005-12-18
CN1327793A (en) 2001-12-26
NO315610B3 (en) 2003-09-29
NZ333777A (en) 2000-07-28
SI9720045A (en) 1999-10-31
PL195762B1 (en) 2007-10-31
CN1388126A (en) 2003-01-01

Similar Documents

Publication Publication Date Title
EP1021185A4 (en) Didhydropyrimidines and uses thereof
EP0894807A4 (en) GPIb-LIPID COMPLEX AND USES THEREOF
ZA9711141B (en) Novel ketobenzamides and their use
GB9620390D0 (en) Substances and their uses
DE59700372D1 (en) Blockcopolymere
GB9625899D0 (en) Substances and their uses
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
PL329351A1 (en) Piperidines and pyrolydines
HK1021117A1 (en) Candy-toy and method thereof
EP0836617A4 (en) Parevins and tachytegrins
GB9609339D0 (en) Device and assembly
PL331523A1 (en) Azolotrizines and azolopyrimidines
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
PL328334A1 (en) Preparation and application thereof
EP0998578A4 (en) Sel-10 AND USES THEREOF
GB9623539D0 (en) Enzymes and their use
GB9625686D0 (en) Tapered speeddeck
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9616563D0 (en) Compounds and methods
PL341293A1 (en) Beta-lypothropin and application thereof
AU131132S (en) Handleset
EP0934345A4 (en) Compounds and methods
GB9624905D0 (en) MNGEF and homologues thereof
GB9618423D0 (en) Structure and device